| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,034,376 ) |
| | 2025 | 2025 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R44DK136463 | A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 2 | NIH | 2/17/2025 | $1,034,376 |
| | 2025 | 2022 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R43DK133040 | A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 1 | NIH | 2/17/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $2,223,129 ) |
| | 2024 | 2024 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R44DK136463 | A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 1 | NIH | 1/15/2024 | $1,006,408 |
| | 2024 | 2024 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R44HL162137 | Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | 000 | 3 | NIH | 8/30/2024 | $1,216,721 |
| | 2024 | 2022 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R43DK133040 | A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 1 | NIH | 8/5/2024 | $0 |
| | 2024 | 2022 | CERIA THERAPEUTICS INC | 1230 N CHERRY AVE | TUCSON | AZ | 85721-0001 | PIMA | USA | R43HL162137 | Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | 000 | 1 | NIH | 12/19/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $807,362 ) |
| | 2023 | 2023 | CERIA THERAPEUTICS INC | 3795 LAKEBRIAR DR | BOULDER | CO | 80304-1002 | BOULDER | USA | R44HL162137 | Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | 000 | 2 | NIH | 9/15/2023 | $807,362 |
| | 2023 | 2022 | CERIA THERAPEUTICS, INC. | 3795 LAKEBRIAR DR | BOULDER | CO | 80304-1002 | BOULDER | USA | R43DK133040 | A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 1 | NIH | 10/25/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $598,520 ) |
| | 2022 | 2022 | CERIA THERAPEUTICS, INC. | 3795 LAKEBRIAR DR | BOULDER | CO | 80304-1002 | BOULDER | USA | R43DK133040 | A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | 000 | 1 | NIH | 9/16/2022 | $299,249 |
| | 2022 | 2022 | CERIA THERAPEUTICS, INC. | 3795 LAKEBRIAR DR | BOULDER | CO | 80304-1002 | BOULDER | USA | R43HL162137 | Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | 000 | 1 | NIH | 3/21/2022 | $299,271 |
|
|
